IPSEN BioPharmaceuticals, Inc.
- Partner Level
- Company Headquarters
- Cambridge, MA
Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we focus our resources, investments and energy on discovering, developing and commercializing medicines in three key therapeutic areas – Oncology, Rare Disease and Neuroscience. We are dedicated to providing hope for patients whose lives are challenged by unmet medical needs. Our North American operations are located in Cambridge, Massachusetts, one of the company’s three global hubs. For more information please visit www.ipsenus.com.
- Ipsen: https://www.ipsen.com/us/
- Somatuline Depot: https://www.somatulinedepot.com
- Onivyde: https://www.onivyde.com
- Ipsen Cares: https://www.ipsencares.com
Ipsen dedicated Patient Access Specialist – Click Here to Read More
Ipsen announces the FDA Approval of Somatuline Depot (lanreotide) Injection for the treatment of gastroenteropancreatic neuroendocrine tumors – Click Here To Read More
New England Journal of Medicine publishes Ipsen’s Somatuline® CLARINET® Phase III results in patients with metastatic gastroenteropancreatic neuroendocrine tumors Click Here to Read More